Drug profile · INN
remimazolam
BYFAVO
remimazolam (BYFAVO) is a gaba-a receptor; anion channel positive allosteric modulator.
EMA: approved NMPA: clinical trials Nervous system (N05) N05CD14
Patents linked 0
Pipeline programs 13
News articles 0
Drug details — remimazolam
- Class
- Nervous system (N05)
- Route
- —
- Patents
- 0
- Programs
- 13
- Data quality
- 0.83
Quick answer
remimazolam (BYFAVO) is a gaba-a receptor; anion channel positive allosteric modulator.
Key facts
INN remimazolam
Brand BYFAVO
Mechanism GABA-A receptor; anion channel positive allosteric modulator
Therapeutic class Nervous system (N05)
ATC code N05CD14
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is remimazolam?
remimazolam (BYFAVO) is a gaba-a receptor; anion channel positive allosteric modulator.
What is the brand name for remimazolam?
BYFAVO is a marketed brand name for remimazolam. Check FDA Drugs@FDA for the current US label holder and prescribing information.